Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 10;12:845936. doi: 10.3389/fonc.2022.845936

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Barco, Lavarello, Cangelosi, Morini, Eva, Oneto, Uva, Tripodi, Garaventa, Conte, Petretto and Cangemi

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Kaplan–Meier estimates and significance of NB patient OS by 3-O-Methyldopa expression. Kaplan-Meier curves show OS of NB patients with high (red) or low (blue) 3-O-Methyldopa expression in a time interval of 5 years. OS is displayed in years. To enhance reliability, data include alive patients with at least 3-years of follow-up. Low or high 3-O-Methyldopa expression was determined according to a cutoff of 454.9 determined with the Elbow method for the second dataset. Plots are relative to (A) All patients, (B), stage M tumors and (C) high-risk patients older than 18 months with stage M tumor. Plots are entitled with the characteristics of the patients in the sub-population. Survival curves were compared by log-rank test. The number of patients with low or high 3-O-Methyldopa expression is reported within brackets in the legend.